Back to search
Retinal Vein Occlusion (RVO)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Retinal Vein Occlusion (RVO) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Retinal Vein Occlusion (RVO) trials you may qualify forThe main goal of this study is to find out how common certain eye diseases are in Germany and how they have changed over time. The diseases being studied are:…
Retinal vein occlusion (RVO), a common retinal vascular disease, is frequently treated with anti-vascular endothelial growth factor (anti-VEGF) agents as first-…
The goal of this clinical trial is to learn about the safety of the investigational medicinal product ANXV. It will also learn about how ANXV works to treat non…
This randomized controlled trial evaluates whether providing clinicians with AI-derived quantitative retinal information improves the quality and efficiency of…
This is a open label, multicenter, Phase II study to evaluate the usability of the pre-filled syringe (PFS) of SB11 (ranibizumab biosimilar). Healthcare Profess…